Orchid Pharma settles patent row, stock up 4%
Orchid Chemicals gained nearly 4% at Rs 105, after touching a high of Rs 106 during the day. Around 862,500 shares were traded at the counter against its two-week average of one million shares. ______________________________________________________________ UCO Bank seeks shareholders" nod for fund raising Negative view on state-run oil cos: Fitch Jan cement sales in high double-digit The stock opened at Rs 104 and surged 5% to a high of Rs 106. It is currently trading with a gain of 4% at Rs 105. Around 326,885 shares have been traded at the BSE so far. The company has informed the BSE through a press release that it has settled its patent litigation with Schering-Plough, a US-based drug major. The issue was related to generic versions of its allergy medication, Clarinex. The agreement marks the end of all pending lawsuits filed and consolidated since 2006 in the US District Court of New Jersey.sameday loan commented:
Good to know that orchid pharmaceuticals gained 4% Great to know that as pharmaceuticals company rising .I liked the post.
20.09.2011
quickquid commented:
Glad to hear such growth of 4 %. Hoping they will raise this growth graph more and more in future.Thanks for such post.
23.11.2011
Quick Quid commented:
Such growth rate was expected from them. They deserve it .I hope they will maintain it in future.
05.12.2011
Wealth Transfer Asia commented:
As the Orchid Pharma settles patent row the stock up 4% . A very positive impact
05.01.2012
Delhi Escort commented:
It is a brilliant post and I would appreciate your great knowledge. Your thoughts are so informative and useful. Keep sharing such new ideas.
09.01.2012
Family Businesses Asia commented:
Excellent post. It is good to see that Orchid Pharma has made a growth of 4%, which is really remarkable, hope it will grow more in future.
11.01.2012
Australia Taxation commented:
You have already helped me adequate and I want to give thanks you for that!You are absolutely powerful on that.Thanks
12.01.2012